<DOC>
	<DOCNO>NCT02293629</DOCNO>
	<brief_summary>This first clinical study BMS-986147 compound healthy subject . The purpose study guide dose range dose frequency future study BMS-986147 provide guideline selection potentially effective dose patient .</brief_summary>
	<brief_title>A Single Multiple Ascending Dose Study Evaluate Safety , Pharmacokinetics , Target Engagement BMS-986147 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy men woman , age 18 45 year Subjects must clinically significant deviation normal : medical history , physical examination , ECGs laboratory evaluation Women child bear potential eligible enrollment . Women must negative pregnancy test Evidence organ dysfunction Any significant acute chronic medical illness Inability : tolerate oral medication , venipunctured</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Subjects</keyword>
</DOC>